Lead Story: Clinical Practice Guideline on the Management of Stimulant Use Disorder American Society of Addiction Medicine and American Academy of Addiction Psychiatry Overdose deaths involving stimulant drugs – including cocaine, methamphetamine, amphetamine, and prescription stimulants – have been rising precipitously over the past decade. In 2021, over fifty percent of overdose deaths in the US involved stimulant drugs. Beyond the mortality risk, stimulant use disorders (StUD) can also lead to long term health problems including infectious diseases, cardiac, pulmonary, psychiatric, dental, nutritional, skin, and cognitive issues. The Clinical Practice Guideline on the Management of Stimulant Use Disorder, developed by the American Society of Addiction Medicine (ASAM) and the American Academy of Addiction Psychiatry (AAAP), provides information on evidence-based strategies and standards of care for the prevention and treatment of stimulant use disorders (StUD), stimulant intoxication, and stimulant withdrawal. Read this issue of the ASAM Weekly Subscribe to the ASAM Weekly Visit ASAM

Ask this episode

“What did the council decide on item 42?” — answered with the speaker and the moment.

Transcript

Related